Publication | Closed Access

Dual-acting agents that possess reversing resistance and anticancer activities: Design, synthesis, MES-SA/Dx5 cell assay, and SAR of Benzyl 1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo[3′,4′:1,2]pyridin[3,4-b]indol-2-substitutedacetates

Molecular PharmacologyMedicinal ChemistryDiversity Oriented SynthesisAnticancer ActivitiesBiochemistryDual-acting AgentsNatural SciencesMedicineDiversity-oriented SynthesisSynthetic ChemistryAnti-cancer AgentHeterocycle ChemistryPharmacologyPharmaceutical ChemistryMes-sa/dx5 Cell AssayDrug DiscoveryDrug Resistance